This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Epitope Limited. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Evgenii Jakovlevich Baiguzin: Innovator in Vaccine Development
Introduction
Evgenii Jakovlevich Baiguzin is a notable inventor based in St. Petersburg, Russia. He has made significant contributions to the field of vaccine development, particularly through his innovative approaches to immunogenic proteins.
Latest Patents
Baiguzin holds 1 patent for a vaccine that comprises a chimeric protein containing immunogenic epitopes of conservative proteins PspA, Spr1895, PsaA, along with flagellin components. These components are connected via flexible links, with the flagellin functioning as an adjuvant, enhancing the vaccine's effectiveness.
Career Highlights
Throughout his career, Baiguzin has been associated with Epitope Limited, where he has focused on advancing vaccine technologies. His work has been instrumental in developing new methods for combating infectious diseases.
Collaborations
Baiguzin has collaborated with notable colleagues, including Aleksandr Nikolaevich Suvorov and Ilya Vladimirovich Dukhovlinov, contributing to various research initiatives and projects.
Conclusion
Evgenii Jakovlevich Baiguzin's innovative work in vaccine development highlights his commitment to improving public health through scientific advancements. His contributions continue to influence the field of immunology and vaccine research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile